Skip to content
Home
About
ABOUT
About Overview
Leadership
Science
Pipeline
Patient & Caregiver Resources
Resources
Clinical Trials & Expanded Access Policy
Spinal Cord Injury
Investors
Investors
Stock Information
Financial Information
Corporate Governance
News Releases
Events & Presentations
Analyst Coverage
In The Media
Contact Us
Home
About
ABOUT
About Overview
Leadership
Science
Pipeline
Patient & Caregiver Resources
Resources
Clinical Trials & Expanded Access Policy
Spinal Cord Injury
Investors
Investors
Stock Information
Financial Information
Corporate Governance
News Releases
Events & Presentations
Analyst Coverage
In The Media
Contact Us
Home
About
ABOUT
About Overview
Leadership
Science
Pipeline
Patient & Caregiver Resources
Resources
Clinical Trials & Expanded Access Policy
Spinal Cord Injury
Investors
Investors
Stock Information
Financial Information
Corporate Governance
News Releases
Events & Presentations
Analyst Coverage
In The Media
Contact Us
Home
About
ABOUT
About Overview
Leadership
Science
Pipeline
Patient & Caregiver Resources
Resources
Clinical Trials & Expanded Access Policy
Spinal Cord Injury
Investors
Investors
Stock Information
Financial Information
Corporate Governance
News Releases
Events & Presentations
Analyst Coverage
In The Media
Contact Us
Select Articles Relevant to NVG-291 and Myelination
05 • 08 • 2026
Modulation of proteoglycan receptor PTPσ enhances MMP-2 activity to promote recovery from multiple sclerosis.
05 • 08 • 2026
Modulating proteoglycan receptor PTPσ using intracellular sigma peptide improves remyelination and functional recovery in mice with demyelinated optic chiasm.
05 • 08 • 2026
LAR and PTPσ receptors are negative regulators of oligodendrogenesis and oligodendrocyte integrity in spinal cord injury.
No posts found